has over 20-plus years of pharmaceutical experience. Brock began his career as a staff clinical hospital pharmacist, working in a progressive clinical environment in the Chicago, IL area. He served in various clinical project management and clinical consultancy roles with Astellas Pharma, Fujisawa, and Eli Lilly, among others. His expertise includes, but is not limited to
on-site CRA monitoring, project management, unblinded CRA assessing investigational project compliance, advising clients on EDC builds and the CRA interface with the EDC system and conducting GCP/Quality Assurance (QA) audits to clinical sites in the USA. Therapeutic areas include Oncology [Solid Organ and Hematologic], Cardiology (Heart Failure and A-Fib Ablation device), Dermatology (Atopic Dermatitis and Psoriasis), Infectious Disease (Pre-Natal Staph vaccine and adult genital HSV Vaccine), Rheumatology (Gout and Lupus), Metabolic (Celiac Disease), Neurology (MS), Radiologic tracers in Prostate Cancer, Transplantation (Solid Organ), Virology (Hepatitis C vaccine) and Neonatal respiratory support (drug delivered via investigational nasal cannula system).